心肌梗塞的新治疗方法
Bingbing Sun1, Long Wang2, Wenmin Guo1
1Department of Critical Care Medicine, The Air Force Characteristic Medical Center, Air Force Medical University, Beijing, China.
Frontiers in cardiovascular medicine
|October 16, 2023
概括
心脏再生医学为心脏病发作恢复提供了新的希望. 心脏组织工程旨在再生受损的心脏肌肉,解决心肌梗塞后心力衰竭目前治疗方法的局限性.
科学领域:
- 心血管医学 心血管医学
- 再生医学是一种再生医学.
- 生物医学工程 生物医学工程
背景情况:
- 冠状动脉样性心血管疾病和急性心肌梗塞的发病率和死亡率很高.
- 目前用于心肌缺血-再输的治疗方法不针对心肌梗塞,导致心力衰竭率增加.
- 急性心肌梗塞死亡率下降有助于心力衰竭的发病率更高.
研究的目的:
- 探索心脏组织工程作为心肌梗塞的创新疗法.
- 讨论心肌再生的心脏组织工程的优势和挑战.
- 为心肌梗塞后心力衰竭的临床治疗提供参考.
主要方法:
- 对心肌再生元件 (细胞,支架,细胞因子) 的研究进行审查.
- 对心肌梗塞的当代创新疗法的分析.
- 对心脏组织工程方法的评估.
主要成果:
- 心脏再生医学提供了一个有前途的新疗法选择.
- 心脏组织工程研究已经确定了心肌再生的关键元素.
- 现有疗法在治疗心肌病理改造和功能减少方面存在局限性.
结论:
- 心脏组织工程提出了一种新的方法来改善心脏病发作后的心脏功能.
- 了解心脏再生的组成部分对于未来的研究至关重要.
- 心脏组织工程为预防和治疗心力衰竭提供了希望.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Angina IV: Management
10
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
10
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11


